Eleazar O. Perez-Macedo

Av. San Fernando No. 22, CP 14080
Tlalpan, DIF 14080, Mexico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

National Clinical Practice Guidelines for the management of non-small cell lung cancer in early, locally advanced and metastatic stages. Extended version.

National Clinical Practice Guidelines for the management of non-small cell lung cancer in early, locally advanced and metastatic stages. Extended version.

Journal: Salud publica de Mexico

Published: July 25, 2018

Survival of Patients with Advanced Non-Small Cell Lung Cancer Enrolled in Clinical Trials.

Survival of Patients with Advanced Non-Small Cell Lung Cancer Enrolled in Clinical Trials.

Journal: Oncology

Published: May 29, 2016

Reduction in Hepatocyte Growth Factor Serum Levels is Associated with Improved Prognosis in Advanced Lung Adenocarcinoma Patients Treated with Afatinib: a Phase II Trial.

Reduction in Hepatocyte Growth Factor Serum Levels is Associated with Improved Prognosis in Advanced Lung Adenocarcinoma Patients Treated with Afatinib: a Phase II Trial.

Journal: Targeted oncology

Published: April 02, 2016

Gene-expression profiles in lung adenocarcinomas related to chronic wood smoke or tobacco exposure.

Gene-expression profiles in lung adenocarcinomas related to chronic wood smoke or tobacco exposure.

Journal: Respiratory research

Published: January 19, 2016

Proposals for the prevention of lung cancer in the health system of Mexico.

Proposals for the prevention of lung cancer in the health system of Mexico.

Journal: Salud publica de Mexico

Published: September 22, 2015

Randomized, open-label trial evaluating the preventive effect of tetracycline on afatinib induced-skin toxicities in non-small cell lung cancer patients.

Randomized, open-label trial evaluating the preventive effect of tetracycline on afatinib induced-skin toxicities in non-small cell lung cancer patients.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: January 28, 2015

Long progression-free survival with first-line paclitaxel plus platinum is associated with improved response and progression-free survival with second-line docetaxel in advanced non-small-cell lung cancer.

Long progression-free survival with first-line paclitaxel plus platinum is associated with improved response and progression-free survival with second-line docetaxel in advanced non-small-cell lung cancer.

Journal: Cancer chemotherapy and pharmacology

Published: May 27, 2014

National consensus of diagnosis and treatment of non-small cell lung cancer

National consensus of diagnosis and treatment of non-small cell lung cancer

Journal: Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion

Published: January 28, 2014

Usefulness of serum carcinoembryonic antigen (CEA) in evaluating response to chemotherapy in patients with advanced non small-cell lung cancer: a prospective cohort study.

Usefulness of serum carcinoembryonic antigen (CEA) in evaluating response to chemotherapy in patients with advanced non small-cell lung cancer: a prospective cohort study.

Journal: BMC cancer

Published: October 08, 2012

Aggressive treatment of primary tumor in patients with non-small-cell lung cancer and exclusively brain metastases.

Aggressive treatment of primary tumor in patients with non-small-cell lung cancer and exclusively brain metastases.

Journal: Clinical lung cancer

Published: February 07, 2012

Showing 1-10 of 10

Last Updated: 09/26/2026